Descriptor English: | Proto-Oncogene Proteins c-met | ||||||
Descriptor Spanish: |
Proteínas Proto-Oncogénicas c-met
| ||||||
Descriptor Portuguese: | Proteínas Proto-Oncogênicas c-met | ||||||
Descriptor French: | Protéines proto-oncogènes c-met | ||||||
Entry term(s): |
HGF Receptor Hepatocyte Growth Factor Receptor MET Proto Oncogene, Receptor Tyrosine Kinase MET Proto-Oncogene, Receptor Tyrosine Kinase MET Receptor Tyrosine Kinase Proto Oncogene Proteins c met Proto-Oncogene Proteins, met Receptor, HGF Receptor, Hepatocyte Growth Factor Receptor, Scatter Factor Scatter Factor Receptor c Met Receptor Tyrosine Kinase c met Proteins c-Met Receptor Tyrosine Kinase c-met Proteins met Proto Oncogene Proteins met Proto-Oncogene Proteins |
||||||
Tree number(s): |
D08.811.913.696.620.682.725.400.075 D12.776.476.568.400.075 D12.776.543.750.630.186 D12.776.543.750.750.400.100 D12.776.624.664.700.186 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D019859 | ||||||
Scope note: | Cell surface protein-tyrosine kinase receptors for HEPATOCYTE GROWTH FACTOR. They consist of an extracellular alpha chain which is disulfide-linked to the transmembrane beta chain. The cytoplasmic portion contains the catalytic domain and sites critical for the regulation of kinase activity. Mutations in the c-met proto-oncogene are associated with papillary renal carcinoma and other neoplasia. |
||||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
Registry Number: | EC 2.7.10.1 | ||||||
Public MeSH Note: | 2006; see PROTO-ONCOGENE PROTEIN C-MET 2000-2005, see PROTO-ONCOGENE PROTEINS C-MET 1998-1999; PROTO-ONCOGENE PROTEIN C-MET was indexed under RECEPTOR PROTEIN-TYROSINE KINASE 1994-1997 & PROTO-ONCOGENE PROTEINS 1989-1993 |
||||||
History Note: | 2006, 1998-1999 |
||||||
DeCS ID: | 33476 | ||||||
Unique ID: | D019859 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1998/01/01 | ||||||
Date of Entry: | 1997/06/20 | ||||||
Revision Date: | 2016/03/09 |
-
-
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
Proto-Oncogene Proteins c-met
- Preferred
Concept UI |
M0029482 |
Scope note | Cell surface protein-tyrosine kinase receptors for HEPATOCYTE GROWTH FACTOR. They consist of an extracellular alpha chain which is disulfide-linked to the transmembrane beta chain. The cytoplasmic portion contains the catalytic domain and sites critical for the regulation of kinase activity. Mutations in the c-met proto-oncogene are associated with papillary renal carcinoma and other neoplasia. |
Preferred term | Proto-Oncogene Proteins c-met |
Entry term(s) |
HGF Receptor Hepatocyte Growth Factor Receptor MET Proto Oncogene, Receptor Tyrosine Kinase MET Proto-Oncogene, Receptor Tyrosine Kinase MET Receptor Tyrosine Kinase Proto Oncogene Proteins c met Proto-Oncogene Proteins, met Receptor, HGF Receptor, Hepatocyte Growth Factor Receptor, Scatter Factor Scatter Factor Receptor c Met Receptor Tyrosine Kinase c met Proteins c-Met Receptor Tyrosine Kinase c-met Proteins met Proto Oncogene Proteins met Proto-Oncogene Proteins |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey